secwatch.observer — SEC 8-K summary
======================================

Issuer:     Onconetix, Inc. (ONCO)
CIK:        0001782107
Form:       8-K
Filed at:   2025-06-05T23:59:59+00:00
Accession:  0001213900-25-051573
Event type: other_material
Sentiment:  negative
Materiality: 0.60
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Onconetix shareholders approve reverse stock split ratio range 1:10 to 1:150
----------------------------------------------------------------------------

- Reverse stock split proposal approved: 11,956,279 For, 4,222,940 Against, 153,929 Abstentions.
- Board authorized to select exact ratio (1-for-10 to 1-for-150) anytime within one year of May 30, 2025.
- Adjournment proposal also approved: 13,570,278 For, 2,367,590 Against, 395,280 Abstentions.
- 44,358,422 shares of common stock were outstanding as of the April 14, 2025 record date.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1782107/000121390025051573/0001213900-25-051573-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1782107/000121390025051573/ea0244883-8k_onconetix.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-051573

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer